SOX4 and non-small cell lung carcinoma: As shown in Fig. 6a, HIF-1α, CASC15, SOX4, and β-catenin were aberrantly overexpressed in a substantial proportion of NSCLC patients (45.7%, 16/35), while in normal lung tissues their expressions were nearly absent.